Form 8-K - Current report:
SEC Accession No. 0001628908-24-000015
Filing Date
2024-02-22
Accepted
2024-02-22 16:18:42
Documents
17
Period of Report
2024-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 02.21.2024 8-K evh-20240222.htm   iXBRL 8-K 30291
2 EX-99.1 a4q23exhibit991.htm EX-99.1 466248
7 evhnewlogo.jpg GRAPHIC 30853
  Complete submission text file 0001628908-24-000015.txt   737244

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20240222.xsd EX-101.SCH 2211
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evh-20240222_def.xml EX-101.DEF 14966
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20240222_lab.xml EX-101.LAB 29174
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20240222_pre.xml EX-101.PRE 15620
18 EXTRACTED XBRL INSTANCE DOCUMENT evh-20240222_htm.xml XML 2847
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 24665091
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)